Pending shareholder approval. There were no retail investors in...

Pending shareholder approval. There were no retail investors in the $13 million. So $13 million to 708s at 8c and up to $2 million for retail at 8c if shareholder approved. Double dare you to go onto their thread and ask how many retail got the 8c shares?
BOD recently said they had enough cash to get them through to next year after the readout.

You are trying to cherry-pick. A large dilution just prior to a pivotal announcement over there. CHM have no drug as advanced as ATL1102 yet.

Getting the accountant to sign the 708 form isn't a bad idea.